PaMeLa Inc. is pleased to announce that it has been selected for the 2nd Phase of the “J-StarX Medtech Program,” a global expansion support program for medical and healthcare startups jointly organized by JETRO (Japan External Trade Organization) and Medtech Actuator, following a competitive pitch process.

Fifteen companies were selected for Phase 1, and seven companies, including PaMeLa, have advanced to Phase 2. In addition to specialized mentoring sessions focused on business strategy and commercialization in Australia, the program includes an in-country immersion component. Through these activities, PaMeLa will further strengthen its network in Australia and accelerate collaboration and validation efforts toward practical implementation in clinical settings.